Bit disappointed in the FY24 results because we appear to have a promotional CEO who uses ‘underlying’ mumbo jumbo and other tricks to mask the results. There is a $10m diff between ‘underlying’ NPAT and statutory NPAT.
Example: He quotes FY24 revenue at $215m but the P&L states $208m (Technically they are correct in that the receipts were $215m but they forgot to reflect the loss on selling of ex hire gear as the difference – nor is it shown in the D&A entry).
The actual EPS are static year on year, and whilst we shareholders got a higher dividend, one could argue that the extra borrowings were contributing to them – must be, because the operating cash flow was just 70% of the NPAT + non-cash items (viz D&A of some $20m). Quoting EPS prior to significant items of 11.6c is absolute malarkey – it is 8.5c period! Not brilliant – earnings growth is ZERO!
So, after all the hype, who were the actual winners?
The tax department, definitely, the FY24 tax rate was 34% v 18.6% in FY23.
I’m hoping the vendors of the businesses we have acquired are not winners but that is yet to play out.
And management have done pretty good as well another 2.623m in options converted to shares (about the same as previous year) and yet there are still $4.674m in the share-based option payments reserve. Man, I’d like to get my nose in that trough!
All I can say is StevenBoland, the stage is yours, NOW is the time to put REAL meat on the FY25 EPSand dividends. Time to fire up and please, put way the ‘smoke and mirrors’.
Yep net debt at around 50% of equity is high enough for the moment. Let's make FY25 a year when we eat into that debt.
Maybe a year of cosolidating the businesses acquired as well.
- Forums
- ASX - By Stock
- Ann: FY24 Full Year Results Presentation
ACF
acrow limited
Add to My Watchlist
0.51%
!
98.5¢

Bit disappointed in the FY24 results because we appear to have...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
98.5¢ |
Change
-0.005(0.51%) |
Mkt cap ! $303.3M |
Open | High | Low | Value | Volume |
98.0¢ | 99.0¢ | 97.5¢ | $221.7K | 225.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 107627 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 0.985 |
1 | 15826 | 0.980 |
4 | 19033 | 0.975 |
5 | 40869 | 0.970 |
4 | 33036 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 107627 | 6 |
0.995 | 10000 | 1 |
1.000 | 16900 | 1 |
1.010 | 10927 | 2 |
1.020 | 4000 | 1 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online